Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is
curable in less than 50% of patients. Prognostic models based on pre-treatment …
curable in less than 50% of patients. Prognostic models based on pre-treatment …
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
MA Shipp, KN Ross, P Tamayo, AP Weng… - Nature …, 2002 - scholars.uthscsa.edu
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is
curable in less than 50% of patients. Prognostic models based on pre-treatment …
curable in less than 50% of patients. Prognostic models based on pre-treatment …
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
MA Shipp, KN Ross, P Tamayo, AP Weng… - Nature …, 2002 - pubmed.ncbi.nlm.nih.gov
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is
curable in less than 50% of patients. Prognostic models based on pre-treatment …
curable in less than 50% of patients. Prognostic models based on pre-treatment …
[PDF][PDF] DIFFUSE LARGE B-CELL LYMPHOMA OUTCOME PREDICTION BY GENE EXPRESSION PROFILING AND SUPERVISED MACHINE LEARNING
MA Shipp, KN Ross, P Tamayo, AP Weng, JL Kutok… - 2001 - pubs.broadinstitute.org
Frozen diagnostic nodal tumor specimens from 58 DLBCL patients and 19 FL patients were
selected for these initial studies. A summary of the clinical data for the patients can be found …
selected for these initial studies. A summary of the clinical data for the patients can be found …
[PDF][PDF] Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
MA SHIPP, KENN ROSS, P TAMAYO, AP WENG… - NATURE …, 2002 - cbio.ensmp.fr
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is
curable in less than 50% of patients. Prognostic models based on pre-treatment …
curable in less than 50% of patients. Prognostic models based on pre-treatment …
[引用][C] Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
S MA - Nat Med, 2002 - cir.nii.ac.jp
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and
supervised machine learning | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
supervised machine learning | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[PDF][PDF] Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
MA SHIPP, KENN ROSS… - NATURE …, 2002 - members.cbio.mines-paristech.fr
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is
curable in less than 50% of patients. Prognostic models based on pre-treatment …
curable in less than 50% of patients. Prognostic models based on pre-treatment …
[PDF][PDF] Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
MA SHIPP, KENN ROSS, P TAMAYO… - NATURE …, 2002 - marcottelab.org
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is
curable in less than 50% of patients. Prognostic models based on pre-treatment …
curable in less than 50% of patients. Prognostic models based on pre-treatment …
[PDF][PDF] DIFFUSE LARGE B-CELL LYMPHOMA OUTCOME PREDICTION BY GENE EXPRESSION PROFILING AND SUPERVISED MACHINE LEARNING
MA Shipp, KN Ross, P Tamayo, AP Weng, JL Kutok… - 2001 - Citeseer
Frozen diagnostic nodal tumor specimens from 58 DLBCL patients and 19 FL patients were
selected for these initial studies. A summary of the clinical data for the patients can be found …
selected for these initial studies. A summary of the clinical data for the patients can be found …
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
MA Shipp, KN Ross, P Tamayo, AP Weng… - Nature …, 2002 - europepmc.org
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is
curable in less than 50% of patients. Prognostic models based on pre-treatment …
curable in less than 50% of patients. Prognostic models based on pre-treatment …